fbpx

Last of the 2021 FDA-Approved Drugs: Sole Drugs Approved in their Indications

A first-in-class intravenous kappa opioid receptor (KOR) agonist, an oral soluble guanylate cyclase (sGC) stimulator, a first-in-class subcutaneous complement C3 inhibitor, and an oral contraceptive comprising a synthetic progesterone (drospirenone) and a plant-based estrogen (estetrol) make up the final group of novel drugs from 2021 that we didn’t cover in our other indication-specific reviews. In 2021, the FDA approved four new drugs for various other indications, from rare diseases to pregnancy prevention.

This article and slide deck explores each in more detail, including but not limited to their:

  • mechanisms of action
  • target rationale
  • disease context
  • original patents
  • key clinical data
  • industry history

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.



already a member? log in:

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

This field is for validation purposes and should be left unchanged.
Newsletter